Single-Blind Participant Masking¶
Design — instantiates Blinding and Expectancy Bias Reduction
Masks the recipient alone from knowing which condition they received, while implementers stay informed.
Sometimes only one role can, or needs to, be masked. Single-Blind Participant Masking blinds the recipient — and only the recipient — so that their own reports and behavior are not shaped by knowing their arm, while the staff delivering the intervention stay deliberately informed. Its defining move is the asymmetry: it is a one-sided mask that consciously accepts provider-side expectancy in exchange for feasibility or operational necessity. That single-sidedness is exactly what distinguishes it from the Double-Blind Trial Protocol, which pays extra to mask the deliverer as well.
Example¶
An exercise-science lab is studying whether a creatine supplement improves sprint performance. The athletes receive coded pouches — creatine or a taste-and-color-matched maltodextrin placebo — and are not told which they are taking, so their self-reported fatigue, perceived effort, and adherence are not colored by expectation. But their coaches do know each athlete's assignment, because the coaches manage training loads and must watch for issues; masking them is neither feasible nor safe here. The design is honest about this: the athlete side of the expectancy pathway is closed, the coach side is left explicitly open, and the write-up says exactly who was blinded and who was not.
How it works¶
The design masks a single role and documents why the others are not. The recipient is blinded through neutral labeling plus a credible comparator convincing enough that they cannot self-diagnose their arm. The provider is left informed by design — because their knowledge is operationally required or masking them is impractical — and that choice is stated rather than glossed. The asymmetry is the whole point, and naming it is what keeps the design from over-claiming.
Tuning parameters¶
- Masked role choice — which single role is blinded (usually the recipient), driven by where the strongest expectancy pathway runs.
- Comparator credibility — how convincing the alternative must be to keep the recipient's blind, given how attentive they are to cues.
- Provider-disclosure scope — how much the informed staff are told, trading operational need against leakage risk.
- Cue management — how side effects and other tells are handled, since the recipient can still self-unblind through them.
- Blind duration — how long recipient masking is maintained.
When it helps, and when it misleads¶
Its strength is pragmatic: it is far cheaper and simpler than double-blinding and still closes the recipient's channel, controlling demand characteristics — the tendency of participants to behave according to what they infer the study wants.[1] Its failure mode is precisely the side it leaves open: provider expectancy and differential care run unchecked, so a knowing coach, clinician, or teacher can still bias delivery. And recipients can self-unblind through side effects the mask did not anticipate. The classic misuse is calling such a study "blinded" full stop, without noting that only one side was. The guarding discipline is to pair it with independent blinded outcome assessment so the informed provider cannot also bias the measurement, to hold the provider's interaction as uniform as one informally can, and to report exactly who was masked.
How it implements the components¶
condition_identity_mask— the recipient sees only a neutral, coded condition with no arm attached.credible_comparator_experience— a comparator believable enough to the recipient that they cannot tell it from the active condition.role_specific_information_boundary— the boundary is drawn around a single role, deliberately placing only the recipient inside the mask and leaving the provider outside it.
It does not equalize an also-masked deliverer's behavior through script_and_interaction_standardization — that second-sided masking is the job of Double-Blind Trial Protocol. Single-blind leaves the provider knowingly unmasked rather than standardizing a provider who is also in the dark.
Related¶
- Instantiates: Blinding and Expectancy Bias Reduction — the lightweight, one-sided masking design.
- Consumes: Sham or Placebo Control supplies the credible comparator the recipient's blind depends on.
- Sibling mechanisms: Blind Integrity Questionnaire · Blinded Data Analysis Plan · Blinded Outcome Adjudication · Central Randomization and Masking Service · Double-Blind Trial Protocol · Emergency Unblinding Procedure · Masked Label Codebook
Editorial Notes¶
Form Classification¶
Form family: Structure, Architecture & Configuration
Rationale: Single-Blind Participant Masking operates as a configured physical, technical, or logical arrangement whose structure creates the effect because it masks the recipient alone from knowing which condition they received, while implementers stay informed.
Independent corroboration: The frozen evidence defines Single-Blind Participant Masking as 'Masks the recipient alone from knowing which condition they received, while implementers stay informed', so its operative form is Structure, Architecture & Configuration.
Nearest alternative: Experiment, Test & Rehearsal — Single-Blind Participant Masking includes features of an active test, trial, simulation, drill, or rehearsal that generates evidence through a deliberate attempt or perturbation, but its defining operation is a configured physical, technical, or logical arrangement whose structure creates the effect.
Review outcome: Independent reviewer agreement; medium confidence.
Origin Attribution¶
Primary origin: Statistics & Experimental Design
Origin pattern: Single lineage
Present-day reach: Multi-domain
Rationale: Masking participants but not implementers is the standard single-blind experimental design.
Related originating lineages:
- Data Science & Analytics — Data science, analytics, and operational monitoring supplies a parallel or contributing lineage for the mechanism's defining operation: masks the recipient alone from knowing which condition they received, while implementers stay informed.
- Mathematics — Mathematical modeling, proof, and abstract-structure practice supplies a parallel or contributing lineage for the mechanism's defining operation: masks the recipient alone from knowing which condition they received, while implementers stay informed.
- Medicine & Healthcare — Clinical trials use participant masking to reduce expectation-related bias.
- Pharmacology & Toxicology — Drug studies institutionalized matched conditions and blinding procedures.
- Psychology — Demand characteristics and placebo effects explain the masking need.
Review resolution: The blind reviewers agree that statistics_experimental_design is the primary origin and differ only on alternate origin disagreement, domain reach disagreement. I preserve every independently explained alternate from both records rather than imposing a numeric cap. I retain single_lineage because the combined evidence shows one traceable formative lineage. The broader reach of multi_domain records portability separately from historical provenance; encyclopedia_synthesis=false preserves the affirmative synthesis judgment where either reviewer identified one.
Review outcome: Reconciled after independent review; high confidence.
References¶
[1] Demand characteristics (Martin Orne, 1962) are the cues in a study that lead participants to guess its purpose and adjust their behavior to match it; masking the recipient from their condition removes the strongest such cue, which is why single-blind designs target the participant even when the provider cannot be blinded. withdrawn registry ↩